The Discounted Cash Flow (DCF) valuation of 10X Genomics Inc (TXG) is (62.10) USD. With the latest stock price at 12.06 USD, the upside of 10X Genomics Inc based on DCF is -614.9%.
Based on the latest price of 12.06 USD and our DCF valuation, 10X Genomics Inc (TXG) is a sell. selling TXG stocks now will result in a potential gain of 614.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 7.7% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (123.88) - (41.78) | (62.10) |
| Upside | -1127.2% - -446.5% | -614.9% |